Invention Grant
US09540348B2 Imidazole-1-yl pyrimidine derivatives, or pharmacutically acceptable salt thereof, and pharmaceutic composition comprising the same as an active ingredient
有权
咪唑-1-基嘧啶衍生物或其药物学上可接受的盐，以及包含其作为活性成分的药物组合物
- Patent Title: Imidazole-1-yl pyrimidine derivatives, or pharmacutically acceptable salt thereof, and pharmaceutic composition comprising the same as an active ingredient
- Patent Title (中): 咪唑-1-基嘧啶衍生物或其药物学上可接受的盐，以及包含其作为活性成分的药物组合物
-
Application No.: US14713037Application Date: 2015-05-15
-
Publication No.: US09540348B2Publication Date: 2017-01-10
- Inventor: Jung-Mi Hah
- Applicant: Industry-University Cooperation Foundation Hanyang University ERICA Campus
- Applicant Address: KR Ansansi
- Assignee: INDUSTRYUNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
- Current Assignee: INDUSTRYUNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
- Current Assignee Address: KR Ansansi
- Agency: Lex IP Meister, PLLC
- Priority: KR10-2015-0002907 20150108
- Main IPC: B65D25/20
- IPC: B65D25/20 ; B65D83/00 ; C07D403/04 ; C07D403/14 ; C07D401/14 ; C07D405/14
Abstract:
The present invention relates to a novel imidazole-1-yl pyrimidine derivative, a pharmaceutically acceptable salt thereof, and a pharmaceutic composition comprising the same. Since the imidazole-1-yl pyrimidine derivative according to the present invention shows the inhibition activity selectively to BRAF, BRAF mutants, or CRAF, it can be used to a pharmaceutic composition for preventing or treating cancer.
Public/Granted literature
Information query
